17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Unlocking clinically translatable genomic information, including copy number alterations (CNA), from formalin-fixed paraffin-embedded (FFPE) tissue is challenging due to low yields and degraded DNA. We describe a robust, cost-effective low-coverage whole genome sequencing (LC WGS) method for CNA detection using 5 ng of FFPE-derived DNA. CN profiles using 100 ng or 5 ng input DNA were highly concordant and comparable with molecular inversion probe (MIP) array profiles. LC WGS improved CN profiles of samples that performed poorly using MIP arrays. Our technique enables identification of driver and prognostic CNAs in archival patient samples previously deemed unsuitable for genomic analysis due to DNA limitations.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s13073-016-0375-z) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: found
          • Article: not found

          Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

          Comparative genomic hybridization produces a map of DNA sequence copy number as a function of chromosomal location throughout the entire genome. Differentially labeled test DNA and normal reference DNA are hybridized simultaneously to normal chromosome spreads. The hybridization is detected with two different fluorochromes. Regions of gain or loss of DNA sequences, such as deletions, duplications, or amplifications, are seen as changes in the ratio of the intensities of the two fluorochromes along the target chromosomes. Analysis of tumor cell lines and primary bladder tumors identified 16 different regions of amplification, many in loci not previously known to be amplified.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Array comparative genomic hybridization and its applications in cancer.

            Alteration in DNA copy number is one of the many ways in which gene expression and function may be modified. Some variations are found among normal individuals, others occur in the course of normal processes in some species and still others participate in causing various disease states. For example, many defects in human development are due to gains and losses of chromosomes and chromosomal segments that occur before or shortly after fertilization, and DNA dosage-alteration changes occurring in somatic cells are frequent contributors to cancer. Detecting these aberrations and interpreting them in the context of broader knowledge facilitates the identification of crucial genes and pathways involved in biological processes and disease. Over the past several years, array comparative genomic hybridization has proven its value for analyzing DNA copy-number variations. Here, we discuss the state of the art of array comparative genomic hybridization and its applications in cancer, emphasizing general concepts rather than specific results.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Accurate and comprehensive sequencing of personal genomes.

              As whole-genome sequencing becomes commoditized and we begin to sequence and analyze personal genomes for clinical and diagnostic purposes, it is necessary to understand what constitutes a complete sequencing experiment for determining genotypes and detecting single-nucleotide variants. Here, we show that the current recommendation of ∼30× coverage is not adequate to produce genotype calls across a large fraction of the genome with acceptably low error rates. Our results are based on analyses of a clinical sample sequenced on two related Illumina platforms, GAII(x) and HiSeq 2000, to a very high depth (126×). We used these data to establish genotype-calling filters that dramatically increase accuracy. We also empirically determined how the callable portion of the genome varies as a function of the amount of sequence data used. These results help provide a "sequencing guide" for future whole-genome sequencing decisions and metrics by which coverage statistics should be reported.
                Bookmark

                Author and article information

                Contributors
                +613 85596521 , kylie.gorringe@petermac.org
                Journal
                Genome Med
                Genome Med
                Genome Medicine
                BioMed Central (London )
                1756-994X
                15 November 2016
                15 November 2016
                2016
                : 8
                : 121
                Affiliations
                [1 ]Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC Australia
                [2 ]The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC Australia
                [3 ]Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC Australia
                [4 ]Molecular Biomarkers and Translational Genomics Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC Australia
                [5 ]LifePool, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC Australia
                [6 ]Pathology, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC Australia
                [7 ]Molecular Genomics Core Facility, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC Australia
                [8 ]Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC Australia
                [9 ]Department of Pathology, University of Melbourne, Parkville, VIC Australia
                Article
                375
                10.1186/s13073-016-0375-z
                5111221
                27846907
                ad6c9cd4-7f40-4762-bc61-091080f6592a
                © The Author(s). 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 13 September 2016
                : 26 October 2016
                Funding
                Funded by: Australian National Health and Medical Research Council
                Award ID: NHMRC APP1063092
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001026, National Breast Cancer Foundation;
                Funded by: Peter MacCallum Cancer Foundation
                Award ID: 1448
                Funded by: NHMRC Early Career Fellowship
                Award ID: APP1052904
                Award Recipient :
                Funded by: Melbourne International Research Scholarship
                Funded by: Melbourne International Fee Remission Scholarship
                Categories
                Method
                Custom metadata
                © The Author(s) 2016

                Molecular medicine
                low coverage whole genome sequencing (lc wgs),low-input dna,copy number,formalin-fixed paraffin-embedded (ffpe),next generation sequencing

                Comments

                Comment on this article